Abstract CT133: First-in-human trial of 225Actinium-DOTA-daratumumab, an alpha-emitting radioimmunotherapy, in patients with daratumumab-refractory multiple myeloma
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Scott Ryan Goldsmith, Vikram Adhikarla, Murali Janakiram, Michael Rosenzweig, Savita Dandapani, Sarah Lee, Nitya Nathwani, Azra Borogovac, Myo Htut, Theophilus Tandoh, Alex Pozhitkov, Enrico Caserta, Mariam Murtadha, Ni-Chun Tsai, Arnab Chowdhury, Joycelynne Palmer, Jonathan Keats, James Sanchez, Erasmus Poku, Russell Rockne, Paul Yazaki, Jeffrey Wong, John E. Shively, Flavia Pichiorri, Amrita Krishnan
Institutions: City Of Hope National Medical Center, City of Hope
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154689228
Cites:
Cited by:
Related to: